Therapeutic potential of curcumin in diabetic complications

ABSTRACT Diabetes mellitus is an extremely prevalent endocrine disease and a major global public health concern. Diabetic complications, such as retinopathy, nephropathy, neuropathy and cardiovascular disease, are common and majorly impact a patient’s quality of life. Curcumin, the major active component of turmeric, possesses extensive known pharmacological properties, including anti‐inflammatory, antioxidant, and antitumor effects. Increasing evidence suggests that curcumin may offer protection against diabetic complications. The current review focuses on the possible molecular targets and pathways involved in diabetic complications and, in particular, the multi‐target approach of curcumin in attenuating diabetic nephropathy, retinopathy, and neuropathy.

[1]  M. Stevens,et al.  Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats , 2001, Diabetologia.

[2]  A. Sahebkar,et al.  Curcumin, hemostasis, thrombosis, and coagulation , 2018, Journal of cellular physiology.

[3]  Gianni Virgili,et al.  Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. , 2011, The Cochrane database of systematic reviews.

[4]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  H. El-Garhy,et al.  The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[6]  H. Cohly,et al.  Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell injury. , 1998, Free radical biology & medicine.

[7]  Ning Zhang,et al.  Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. , 2006, Molecular vision.

[8]  V. Menon,et al.  Quercetin allievates oxidative stress in streptozotocin‐induced diabetic rats , 2004, Phytotherapy research : PTR.

[9]  L. Howells,et al.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.

[10]  T. Wieman,et al.  Treatment of Hyperesthetic Neuropathic Pain in Diabetics Decompression of the Tarsal Tunnel , 1995, Annals of surgery.

[11]  Peiqing Liu,et al.  Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway , 2013, Molecular and Cellular Endocrinology.

[12]  D. Hardie,et al.  AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.

[13]  M. Bhattacharya,et al.  Curcumin as potential therapeutic natural product: a nanobiotechnological perspective , 2016, The Journal of pharmacy and pharmacology.

[14]  Wei Wu,et al.  Effect of curcumin on rats/mice with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials. , 2014, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[15]  Zhi-Li Huang,et al.  Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved , 2012, Neuropharmacology.

[16]  R. Leibel,et al.  Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. , 2008, Endocrinology.

[17]  R. Kumar,et al.  Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. , 1995, Carcinogenesis.

[18]  D. Pradhan,et al.  Pharmacognostic Evaluation of Curcumin on Diabetic Retinopathy in Alloxan-induced Diabetes through NF-KB and Brn3a Related Mechanism , 2018 .

[19]  E. Wang,et al.  Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling , 2017, BioMed research international.

[20]  S. Chakrabarti,et al.  Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. , 2009, Nutrition.

[21]  S. Asgary,et al.  Treatment of Non‐alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo‐controlled Trial , 2016, Phytotherapy research : PTR.

[22]  Kaili Wu,et al.  Curcumin Alleviates Diabetic Retinopathy in Experimental Diabetic Rats , 2018, Ophthalmic Research.

[23]  S. T. Hosseini,et al.  Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[24]  Chao Liu,et al.  Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats , 2012, PloS one.

[25]  Liping Huang,et al.  Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. , 2011, Kidney international.

[26]  M. Czaja JNK regulation of hepatic manifestations of the metabolic syndrome , 2010, Trends in Endocrinology & Metabolism.

[27]  A. Bansal,et al.  SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[28]  K. Srinivasan,et al.  Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats , 1998, Molecular and Cellular Biochemistry.

[29]  Bo-hou Xia,et al.  Curcumin , 2020, Medicine.

[30]  Z. Ali EVALUATION OF ANTI-DIABETIC AND NEPHRO PROTECTIVE ACTIVITY OF 95% ETHANOLIC EXTRACT OF CANTHIUM DICOCCUM WHOLE PLANT BY USING ALBINO RATS , 2013 .

[31]  A. Sahebkar,et al.  Immune modulation by curcumin: The role of interleukin-10 , 2019, Critical reviews in food science and nutrition.

[32]  H. Kamiya,et al.  Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. , 2004, European journal of pharmacology.

[33]  Jun-Li Liu,et al.  Curcumin and Diabetes: A Systematic Review , 2013, Evidence-based complementary and alternative medicine : eCAM.

[34]  E. Skrzypczak‐Jankun,et al.  Plasminogen activator inhibitor-1 in kidney pathology (Review). , 2013, International journal of molecular medicine.

[35]  C. Pollock,et al.  Increased sphingosine 1‐phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy , 2016, Clinical and Experimental Pharmacology and Physiology.

[36]  H. Haller,et al.  Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. , 2004, Diabetes.

[37]  Wei Sun,et al.  Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. , 2015, Journal of ethnopharmacology.

[38]  P. Suryanarayana,et al.  Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. , 2007, Biochemical and biophysical research communications.

[39]  C. Rao,et al.  Curcumin protects retinal cells from light-and oxidant stress-induced cell death. , 2009, Free radical biology & medicine.

[40]  F. Braet,et al.  KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways , 2016, Scientific Reports.

[41]  Peipei Wang,et al.  Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes , 2016, Cellular Physiology and Biochemistry.

[42]  A. Gaikwad,et al.  Change in post‐translational modifications of histone H3, heat‐shock protein‐27 and MAP kinase p38 expression by curcumin in streptozotocin‐induced type I diabetic nephropathy , 2008, British journal of pharmacology.

[43]  B. Davis,et al.  Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses , 2016, PLoS medicine.

[44]  A. Sahebkar,et al.  Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial , 2018, Drug Research.

[45]  Kenji Suzuki,et al.  Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. , 2011, Molecular nutrition & food research.

[46]  N. Calcutt,et al.  A novel curcumin derivative for the treatment of diabetic neuropathy , 2018, Neuropharmacology.

[47]  K. Dua,et al.  Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. , 2011, European journal of pharmacology.

[48]  K. Srinivasan,et al.  Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats , 2004, Molecular and Cellular Biochemistry.

[49]  A. Straube,et al.  TNF-alpha expression in painful and nonpainful neuropathies , 2001, Neurology.

[50]  M. Ghanei,et al.  Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial , 2016, Journal of dietary supplements.

[51]  Mi-Kyung Lee,et al.  Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. , 2008, Molecular nutrition & food research.

[52]  Y. Panahi,et al.  Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial , 2016, Journal of dietary supplements.

[53]  Beverley Balkau,et al.  The prevalence of and factors associated with diabetic retinopathy in the Australian population. , 2003, Diabetes care.

[54]  L. Gesualdo,et al.  Pathogenetic mechanisms of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[55]  D. Ziegler Treatment of Diabetic Polyneuropathy , 2006, Annals of the New York Academy of Sciences.

[56]  S. Sang,et al.  Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase , 2004 .

[57]  Eva L Feldman,et al.  Diabetic neuropathy: clinical manifestations and current treatments , 2012, The Lancet Neurology.

[58]  G. Dolcini,et al.  Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells , 2008, Archives of Virology.

[59]  Yinfei Yu,et al.  Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats , 2018, Inflammopharmacology.

[60]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[61]  Kenji Suzuki,et al.  Molecular understanding of curcumin in diabetic nephropathy. , 2013, Drug discovery today.

[62]  N. Cooper,et al.  Glutamate-induced NFkappaB activation in the retina. , 2009, Investigative ophthalmology & visual science.

[63]  P. Sil,et al.  Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. , 2015, Toxicology and applied pharmacology.

[64]  I. Benter,et al.  Inhibition of calcium/calmodulin-dependent protein kinase II normalizes diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. , 2003, Autonomic & autacoid pharmacology.

[65]  A. Sahebkar,et al.  Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials. , 2016, Pharmacological research.

[66]  A. Sahebkar,et al.  Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades? , 2018, Journal of cellular physiology.

[67]  Stefan Scholl,et al.  Pathophysiology of Macular Edema , 2010, Ophthalmologica.

[68]  L. Pari,et al.  Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. , 2007, Journal of medicinal food.

[69]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[70]  K. Chopra,et al.  Tocotrienol attenuates oxidative–nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy , 2009, Neuropharmacology.

[71]  M. Lorenzi,et al.  Increased expression of basement membrane collagen in human diabetic retinopathy. , 1994, The Journal of clinical investigation.

[72]  T. Nakaki,et al.  Static Pressure Regulates Connective Tissue Growth Factor Expression in Human Mesangial Cells* 210 , 2001, The Journal of Biological Chemistry.

[73]  C. Gerhardinger,et al.  Müller cell changes in human diabetic retinopathy. , 1998, Diabetes.

[74]  Kenji Suzuki,et al.  Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy , 2011, Nutrition & metabolism.

[75]  K. Chopra,et al.  Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. , 2006, European journal of pharmacology.

[76]  R. Foresti,et al.  Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. , 2000, Free radical biology & medicine.

[77]  V. Menon,et al.  Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin–nicotinamide generated oxidative stress induced diabetes , 2010 .

[78]  T. Wada,et al.  Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[79]  N. Kawai,et al.  Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. , 1998, Acta neurochirurgica. Supplement.

[80]  I. Zagon,et al.  Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. , 2007, Archives of ophthalmology.

[81]  Y. Panahi,et al.  Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial , 2016, Journal of cardiovascular pharmacology.

[82]  A. Ahmed,et al.  Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats , 2012, Behavioural pharmacology.

[83]  G. Cho,et al.  CaMKII regulates pericyte loss in the retina of early diabetic mouse , 2011, Molecules and cells.

[84]  G. Liang,et al.  Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice. , 2017, Toxicology letters.

[85]  B. Gallacher,et al.  Glucose-Induced Protein Kinase C Activation Regulates Vascular Permeability Factor mRNA Expression and Peptide Production by Human Vascular Smooth Muscle Cells In Vitro , 1997, Diabetes.

[86]  N. Alenina,et al.  The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7) , 2017, Physiological reviews.

[87]  L. Cai,et al.  Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation. , 2015, Biochimica et biophysica acta.

[88]  D. Hardie,et al.  AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer , 2013, Diabetes.

[89]  S. Jirawatnotai,et al.  Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. , 2014, The Journal of nutritional biochemistry.

[90]  Afaf D. Abdel-Mageida,et al.  The potential e ff ect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats , 2018 .

[91]  Hai-yan Chi,et al.  Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models , 2017, Saudi journal of biological sciences.

[92]  B. Aggarwal,et al.  Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. , 1998, Biochemical pharmacology.

[93]  A. Sahebkar,et al.  Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review , 2018, Phytotherapy research : PTR.

[94]  K. Chopra,et al.  Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. , 2007, European journal of pharmacology.

[95]  K. Chopra,et al.  CURCUMIN, THE ACTIVE PRINCIPLE OF TURMERIC (CURCUMA LONGA), AMELIORATES DIABETIC NEPHROPATHY IN RATS , 2006, Clinical and experimental pharmacology & physiology.

[96]  Xiaokun Li,et al.  Inhibition of high glucose‐induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats , 2012, British journal of pharmacology.

[97]  S. Gautam,et al.  Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. , 1997, Experimental hematology.

[98]  Y. Panahi,et al.  Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. , 2015, Clinical nutrition.

[99]  D. Panagiotakos,et al.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel# , 2017, Archives of medical science : AMS.

[100]  Anupama E. Gururaj,et al.  Molecular mechanisms of anti-angiogenic effect of curcumin. , 2002, Biochemical and biophysical research communications.

[101]  Xianggen Wu,et al.  Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice , 2016, Scientific Reports.

[102]  De-bao Liu,et al.  Curcumin Attenuates Diabetic Neuropathic Pain by Downregulating TNF-α in a Rat Model , 2013, International journal of medical sciences.

[103]  B. Viollet,et al.  A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. , 2007, American journal of physiology. Renal physiology.

[104]  P. Murugan,et al.  Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. , 2006, Life sciences.

[105]  G. King,et al.  Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. , 1997, The Journal of clinical investigation.

[106]  Lea Joanne DeLoughery,et al.  RAGE , 2018, Springer Reference Medizin.

[107]  R. Atkins,et al.  Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy , 2004, Diabetologia.

[108]  J. Jakobsen Treatment of diabetic polyneuropathy , 1992, Acta neurologica Scandinavica.

[109]  M. Nazıroğlu,et al.  Role of Oxidative Stress and Ca2+ Signaling on Molecular Pathways of Neuropathic Pain in Diabetes: Focus on TRP Channels , 2012, Neurochemical Research.

[110]  M. Zou,et al.  Regulation of interplay between autophagy and apoptosis in the diabetic heart , 2013, Autophagy.

[111]  Y. Liu,et al.  Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia , 2009, Brain Research.

[112]  S. Ryter,et al.  The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-11 , 2009, The Journal of Immunology.

[113]  Zhong-fu Zuo,et al.  Protective effects of curcumin on retinal Müller cell in early diabetic rats. , 2013, International journal of ophthalmology.

[114]  M. Hanani Satellite glial cells in sensory ganglia: from form to function , 2005, Brain Research Reviews.

[115]  T. Orchard,et al.  Psychomotor Slowing Is Associated With Distal Symmetrical Polyneuropathy in Adults With Diabetes Mellitus , 1992, Diabetes.

[116]  Mi Young Lee,et al.  Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy , 2016, Yonsei medical journal.

[117]  Sayon Roy,et al.  Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. , 2003, Diabetes.

[118]  K. Chopra,et al.  Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF‐alpha , 2007, Phytotherapy research : PTR.

[119]  G. Horton,et al.  Flat-mount studies of human retinal vessels. , 1966, American journal of ophthalmology.

[120]  Thomas de Quincey [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.

[121]  G. Belcaro,et al.  Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. , 2012, Panminerva medica.

[122]  Chunping Zhang,et al.  Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia , 2018, Front. Neurosci..

[123]  E. Travis Littledike,et al.  Insulin , 1923, The Indian medical gazette.

[124]  Guowang Xu,et al.  Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. , 2004, Journal of pharmaceutical and biomedical analysis.

[125]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[126]  A. Lin Activation of the JNK signaling pathway: Breaking the brake on apoptosis , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[127]  Y. Ohashi,et al.  Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. , 2000, Kidney international.

[128]  H. Kishida,et al.  Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. , 2005, Biological & pharmaceutical bulletin.

[129]  B. Li,et al.  Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy. , 2015, International journal of ophthalmology.

[130]  P. Salimath,et al.  Antidiabetic property of fenugreek seed mucilage and spent turmeric in streptozotocin-induced diabetic rats , 2005 .

[131]  S. Yim,et al.  Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. , 2004, Journal of pharmacological sciences.

[132]  Timothy S Kern,et al.  Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.

[133]  David R Webb,et al.  Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective , 2015, Postgraduate Medical Journal.

[134]  H. Makino,et al.  Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. , 2011, Acta medica Okayama.

[135]  J. Tang,et al.  Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. , 2001, Diabetes.

[136]  D. Zochodne Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms , 2007, Muscle & nerve.

[137]  H. Parving,et al.  Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. , 2003, Diabetes care.

[138]  A. Sahebkar,et al.  Curcumin as a natural regulator of monocyte chemoattractant protein-1. , 2017, Cytokine & growth factor reviews.

[139]  L. Pari,et al.  Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. , 2007, Journal of ethnopharmacology.

[140]  W. Ling,et al.  Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. , 2012, World journal of diabetes.

[141]  R. Baron,et al.  Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.

[142]  Hong-Zhuan Chen,et al.  Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats , 2005, Acta Pharmacologica Sinica.

[143]  R. Frank Diabetic Retinopathy and Systemic Factors , 2015, Middle East African journal of ophthalmology.

[144]  A. Kashiwagi,et al.  Protein Kinase Cβ Selective Inhibitor LY333531 Attenuates Diabetic Hyperalgesia Through Ameliorating cGMP Level of Dorsal Root Ganglion Neurons , 2003 .

[145]  A. Straube,et al.  TNF-alpha expression in painful and nonpainful neuropathies , 2001, Neurology.

[146]  Y. Panahi,et al.  Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial , 2016, Inflammopharmacology.

[147]  V. Bril Treatments for diabetic neuropathy , 2012, Journal of the peripheral nervous system : JPNS.

[148]  S. Chakrabarti,et al.  Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats , 2012, Diabetes/metabolism research and reviews.

[149]  R. Pop-Busui,et al.  Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now. , 2016, International review of neurobiology.

[150]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[151]  D. Zochodne,et al.  RAGE, diabetes, and the nervous system. , 2007, Current molecular medicine.

[152]  Kenji Suzuki,et al.  Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. , 2013, The Journal of nutritional biochemistry.

[153]  V. Menon,et al.  Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. , 2005, Journal of medicinal food.

[154]  E. Cagliero,et al.  Characteristics and Mechanisms of High-Glucose–Induced Overexpression of Basement Membrane Components in Cultured Human Endothelial Cells , 1991, Diabetes.

[155]  Y. D. Reijmer,et al.  A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus , 2009, Diabetologia.

[156]  Yunes Panahi,et al.  Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. , 2017, Complementary therapies in medicine.

[157]  S. Tesfaye,et al.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.

[158]  D. Cui,et al.  Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation , 2017, Cell Death & Disease.

[159]  A. Sahebkar,et al.  Curcumin: A new candidate for melanoma therapy? , 2016, International journal of cancer.

[160]  H. Banafshe,et al.  Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. , 2014, European journal of pharmacology.

[161]  A. Masamune,et al.  Curcumin blocks activation of pancreatic stellate cells , 2006, Journal of cellular biochemistry.

[162]  S. Adler,et al.  Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC , 2010, BMC complementary and alternative medicine.

[163]  M. Dunlop,et al.  Aldose reductase and the role of the polyol pathway in diabetic nephropathy. , 2000, Kidney international. Supplement.

[164]  M. Haneda,et al.  J Am Soc Nephrol 14: 1374–1382, 2003 Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy , 2022 .

[165]  A. Sahebkar,et al.  Curcumin as a MicroRNA Regulator in Cancer: A Review. , 2016, Reviews of physiology, biochemistry and pharmacology.

[166]  S. S. Agrawal,et al.  Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[167]  Naijil George,et al.  Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats , 2011, Molecular and Cellular Endocrinology.

[168]  R. Flavell,et al.  Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice , 2009, Diabetologia.

[169]  Weiya Ma,et al.  ERKs and p38 Kinases Mediate Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10* , 2000, The Journal of Biological Chemistry.

[170]  A. Somogyi,et al.  Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats , 2006, Neurochemistry International.

[171]  R. Mastrocola,et al.  Oxidative and nitrosative stress in brain mitochondria of diabetic rats. , 2005, The Journal of endocrinology.

[172]  Xiaokun Li,et al.  Targeting JNK by a New Curcumin Analog to Inhibit NF-kB-Mediated Expression of Cell Adhesion Molecules Attenuates Renal Macrophage Infiltration and Injury in Diabetic Mice , 2013, PloS one.

[173]  J. Pfeilschifter,et al.  Sphingosine 1-Phosphate Cross-activates the Smad Signaling Cascade and Mimics Transforming Growth Factor-β-induced Cell Responses* , 2004, Journal of Biological Chemistry.

[174]  D. Jue,et al.  Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. , 2006, Immunology letters.

[175]  T. Kern,et al.  Hyperglycemia as a cause of diabetic retinopathy. , 1986, Metabolism: clinical and experimental.

[176]  R. Manikandan,et al.  Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. , 2011, European journal of pharmacology.

[177]  U. Pendurthi,et al.  Suppression of transcription factor Egr-1 by curcumin. , 2000, Thrombosis research.

[178]  C. Pollock,et al.  The role of toll-like receptors in diabetic kidney disease , 2018, Current opinion in nephrology and hypertension.

[179]  A. Sahebkar,et al.  Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2015, Pain medicine.

[180]  L. Pari,et al.  EFFECT OF TETRAHYDROCURCUMIN ON BLOOD GLUCOSE, PLASMA INSULIN AND HEPATIC KEY ENZYMES IN STREPTOZOTOCIN INDUCED DIABETIC RATS , 2005, Journal of basic and clinical physiology and pharmacology.

[181]  G. Bruno,et al.  Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment , 2015, Endocrine.

[182]  D. Becker,et al.  Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. , 1990, The Journal of pediatrics.

[183]  Linda Greensmith,et al.  Induction of heat shock proteins for protection against oxidative stress. , 2009, Advanced drug delivery reviews.

[184]  M. Diederich,et al.  Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. , 2006, Biochemical pharmacology.

[185]  B. Aggarwal,et al.  Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers , 2013, British journal of pharmacology.

[186]  A. Sahebkar Molecular mechanisms for curcumin benefits against ischemic injury. , 2010, Fertility and sterility.

[187]  J. Chung The role of reactive oxygen species (ROS) in persistent pain. , 2004, Molecular interventions.

[188]  Sushil K. Jain,et al.  Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. , 2009, Antioxidants & redox signaling.

[189]  J. Berger,et al.  Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation , 2003, International Journal of Obesity.

[190]  Cheng Ho,et al.  Curcumin Rescues Diabetic Renal Fibrosis by Targeting Superoxide‐Mediated Wnt Signaling Pathways§, ☆, ☆☆, ☆☆☆ , 2016, The American journal of the medical sciences.

[191]  Li-na Sun,et al.  Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. , 2014, International immunopharmacology.

[192]  M. Chan Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.

[193]  M. James,et al.  NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy , 2016, Scientific Reports.

[194]  M. Banach,et al.  Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes , 2017, Journal of cellular biochemistry.

[195]  Bin Zhang,et al.  Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord , 2014, Neuroscience Letters.

[196]  V. Menon,et al.  Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. , 1993, Metabolism: clinical and experimental.

[197]  H. Haller,et al.  Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. , 2006, Kidney international.

[198]  B. Aggarwal,et al.  Curcumin: Getting Back to the Roots , 2005, Annals of the New York Academy of Sciences.

[199]  M. Caraglia,et al.  Vascular endothelial growth factor: An important molecular target of curcumin , 2019, Critical reviews in food science and nutrition.

[200]  Li Qin,et al.  Suppression of corneal neovascularization by curcumin via inhibition of Wnt/β-catenin pathway activation. , 2017, International journal of ophthalmology.

[201]  H. Yamanaka,et al.  Expression of ATP receptors in the rat dorsal root ganglion and spinal cord , 2012, Anatomical Science International.

[202]  V. Rangnekar,et al.  Suppression of growth and transformation and induction of apoptosis by EGR-1. , 1998, Cancer gene therapy.

[203]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[204]  A. Sahebkar,et al.  Curcumin: An Effective Inhibitor of Interleukin-6. , 2017, Current pharmaceutical design.

[205]  A. Gotto,et al.  Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials , 2019, Critical reviews in food science and nutrition.

[206]  Amirhosein Sahebkar,et al.  Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential , 2018, Journal of cellular physiology.

[207]  H. Kishida,et al.  Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. , 2005, Journal of agricultural and food chemistry.

[208]  Xiaokun Li,et al.  Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. , 2013, The Journal of nutritional biochemistry.

[209]  P. Suryanarayana,et al.  Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. , 2005, Investigative ophthalmology & visual science.

[210]  Ju Hwan Lee,et al.  Antidiabetic Potential of the Heme Oxygenase-1 Inducer Curcumin Analogues , 2013, BioMed research international.

[211]  Geert Jan Biessels,et al.  The effects of type 1 diabetes on cognitive performance: a meta-analysis. , 2005, Diabetes care.

[212]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[213]  Eileen D. Adamson,et al.  A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization , 1988, Cell.

[214]  G. Romeo,et al.  Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.

[215]  G. Yan,et al.  Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia , 2007, Diabetes.

[216]  A. Sahebkar Curcuminoids for the management of hypertriglyceridaemia , 2014, Nature Reviews Cardiology.

[217]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[218]  Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials , 2015 .